術中神経モニタリング市場：タイプ、モダリティ、アプリケーション別-2025-2030年の世界予測

術中神経モニタリング市場は、2023年に31億3,000万米ドルと評価され、2024年には33億1,000万米ドルに達すると予測され、CAGR 5.69％で成長し、2030年には46億2,000万米ドルになると予測されています。

術中神経モニタリング（IONM）は、神経経路をリアルタイムで監視し、神経や脊髄の損傷リスクを低減するために手術中に使用される特殊な処置です。IONMの必要性は、外科医に即座にフィードバックを提供し、特に脳、脊椎、神経を含む複雑な手術中の患者の安全性を高めることができることに由来します。IONMの用途は幅広く、整形外科、神経外科、血管外科、耳鼻咽喉科に及ぶ。最終用途には病院、手術センター、専門クリニックなどが含まれ、手術件数の増加や手術合併症を最小限に抑えたいという要望が需要を牽引しています。

市場の洞察によると、技術的進歩、より多くの手術を必要とする高齢化、患者の安全性に関するヘルスケア専門家の意識の高まりなど、成長に影響を与えるいくつかの主要要因が明らかになった。ヘルスケア・インフラが拡大する新興市場や、モニタリング精度と予測分析を強化するための人工知能と機械学習の統合にはビジネスチャンスが豊富です。こうした機会を捉えるため、企業はこれらの地域でのプレゼンス拡大と、より洗練された使いやすい機器の研究開発への投資に注力すべきです。

市場の成長を阻害する課題としては、機器コストの高さ、IONM技術を運用する熟練専門家の不足、複雑な規制上のハードルなどが挙げられます。さらに、技術革新のペースが速いため、ヘルスケアプロバイダーは常に適応する必要があり、これが普及の障壁となる可能性があります。

技術革新は、費用対効果の高いソリューションの開発、ワイヤレス接続と他の手術システムとの相互運用性の強化に集中すべきです。非侵襲的モニタリング技術の調査により、事業成長の新たな道が開ける可能性があります。IONM市場の性質はダイナミックであり、絶え間ない技術革新と競合情勢が特徴です。企業は、競争力を維持するために、戦略的パートナーシップ、継続的な技術更新、ヘルスケア専門家向けの包括的なトレーニングプログラムを優先すべきです。これらの課題に積極的に取り組み、新技術を活用することで、企業は成長を促進し、市場での存在感を高めることができます。

市場力学：急速に進化する術中神経モニタリング市場の主要市場インサイトを公開

術中神経モニタリング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 様々なライフスタイルに関連する慢性疾患の有病率の増加
  • 好意的な償還政策と、より安全な手術に対する需要
  • アウトソーシングの動向の高まり術中神経モニタリング
• 市場抑制要因
  • 治療費の高騰
• 市場機会
  • 手術中のリスクを最小化するための神経モニタリングの技術的進歩
  • 政府機関による研究開発投資の増加
• 市場の課題
  • 熟練した専門家の不足と認知度の低さ

ポーターのファイブフォース：術中神経モニタリング市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：術中神経モニタリング市場における外部からの影響の把握

外部マクロ環境要因は、術中神経モニタリング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析術中神経モニタリング市場における競合情勢の把握

術中神経モニタリング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス術中神経モニタリング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、術中神経モニタリング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨術中神経モニタリング市場における成功への道筋を描く

術中神経モニタリング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • さまざまなライフスタイルに関連する慢性疾患の増加
    • 有利な償還方針とより安全な手術方法の要求
    • アウトソーシングの増加傾向術中神経モニタリング
  • 抑制要因
    • 治療費が高い
  • 機会
    • 手術中のリスクを最小限に抑える神経モニタリングの技術的進歩
    • 政府機関による研究開発投資の増加
  • 課題
    • 熟練した専門家の不足と意識の低さ
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 術中神経モニタリング市場：タイプ別

• インソースIONM
• IONMをアウトソーシング

第7章 術中神経モニタリング市場：モダリティ別

• 脳幹聴覚誘発電位
• 脳波検査
• 筋電図検査
• 運動誘発電位
• 体性感覚誘発電位
• 視覚誘発電位

第8章 術中神経モニタリング市場：用途別

• 耳鼻咽喉科手術
• 脳神経外科
• 整形外科
• 脊椎手術
• 血管外科

第9章 南北アメリカの術中神経モニタリング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の術中神経モニタリング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの術中神経モニタリング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Accurate Monitoring, LLC
• Argos Neuromonitoring LP
• Biotronic NeuroNetwork, LLC
• Cadwell Industries, Inc.
• Computational Diagnostics, Inc.
• Emotiv Inc.
• inomed Medizintechnik GmbH
• Intranerve, LLC
• Medsurant Health
• Medtronic PLC
• Moberg Research Inc.
• Natus Medical Incorporated
• NeuroMonitoring Technologies
• NeuroSentinel LLC
• Nihon Kohden Corporation
• NuVasive Inc
• Procirca
• ProPep Surgical
• SpecialtyCare, Inc.

LIST OF FIGURES

• FIGURE 1. INTRAOPERATIVE NEUROMONITORING MARKET RESEARCH PROCESS
• FIGURE 2. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. INTRAOPERATIVE NEUROMONITORING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. INTRAOPERATIVE NEUROMONITORING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. INTRAOPERATIVE NEUROMONITORING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INTRAOPERATIVE NEUROMONITORING MARKET DYNAMICS
• TABLE 7. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY INSOURCE IONM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY OUTSOURCE IONM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY BRAINSTEM AUDITORY EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ELECTROMYOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MOTOR EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY SOMATOSENSORY EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY VISUAL EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ENT SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. CANADA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CANADA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 35. CANADA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. CHINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. CHINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 52. CHINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 55. INDIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. ITALY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. ITALY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 107. ITALY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. POLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. POLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 119. POLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. QATAR INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. QATAR INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 122. QATAR INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. INTRAOPERATIVE NEUROMONITORING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 151. INTRAOPERATIVE NEUROMONITORING MARKET, FPNV POSITIONING MATRIX, 2023

The Intraoperative Neuromonitoring Market was valued at USD 3.13 billion in 2023, expected to reach USD 3.31 billion in 2024, and is projected to grow at a CAGR of 5.69%, to USD 4.62 billion by 2030.

Intraoperative neuromonitoring (IONM) is a specialized procedure used during surgeries to monitor the neural pathways in real-time, reducing the risk of nerve or spinal cord damage. The necessity of IONM stems from its ability to provide immediate feedback to surgeons, enhancing patient safety, particularly during complex surgeries involving the brain, spine, and nerves. Its applications are broad, spanning orthopedic, neurosurgical, vascular, and ENT procedures. The end-use scope includes hospitals, surgical centers, and specialty clinics, where demand is driven by the increasing volume of surgeries and the desire to minimize surgical complications.

Market insights reveal several key factors influencing growth, including technological advancements, an aging population requiring more surgeries, and increasing awareness among healthcare professionals about patient safety benefits. Opportunities abound in emerging markets, where healthcare infrastructure is expanding, and in the integration of artificial intelligence and machine learning to enhance monitoring accuracy and predictive analytics. To seize these opportunities, companies should focus on expanding their presence in these regions and investing in R&D for more sophisticated, user-friendly devices.

Challenges impeding market growth include high equipment costs, a shortage of skilled professionals to operate IONM technologies, and complex regulatory hurdles. Furthermore, the rapid pace of technological change demands constant adaptation by healthcare providers, which can be a barrier for widespread adoption.

Innovation should concentrate on developing cost-effective solutions and enhancing wireless connectivity and interoperability with other surgical systems. Research into non-invasive monitoring techniques could offer new avenues for business growth. The nature of the IONM market is dynamic, characterized by continuous technological innovations and a competitive landscape. Businesses should prioritize strategic partnerships, continuous technological updates, and comprehensive training programs for healthcare professionals to maintain a competitive edge. By being proactive in addressing these challenges and leveraging new technologies, businesses can drive growth and establish a strong market presence.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intraoperative Neuromonitoring Market

The Intraoperative Neuromonitoring Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of various lifestyles associated chronic diseases
  • Favorable reimbursement policies and demand for safer surgery practices
  • Rising trend of outsourcing Intraoperative Neuromonitoring
• Market Restraints
  • High cost of treatment
• Market Opportunities
  • Technological advancements in neuromonitoring to minimize the risks during surgery
  • Increased R&D investments by governmental bodies
• Market Challenges
  • Dearth of skilled professionals and low awareness

Porter's Five Forces: A Strategic Tool for Navigating the Intraoperative Neuromonitoring Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intraoperative Neuromonitoring Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intraoperative Neuromonitoring Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intraoperative Neuromonitoring Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intraoperative Neuromonitoring Market

A detailed market share analysis in the Intraoperative Neuromonitoring Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intraoperative Neuromonitoring Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intraoperative Neuromonitoring Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intraoperative Neuromonitoring Market

A strategic analysis of the Intraoperative Neuromonitoring Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intraoperative Neuromonitoring Market, highlighting leading vendors and their innovative profiles. These include Accurate Monitoring, LLC, Argos Neuromonitoring LP, Biotronic NeuroNetwork, LLC, Cadwell Industries, Inc., Computational Diagnostics, Inc., Emotiv Inc., inomed Medizintechnik GmbH, Intranerve, LLC, Medsurant Health, Medtronic PLC, Moberg Research Inc., Natus Medical Incorporated, NeuroMonitoring Technologies, NeuroSentinel LLC, Nihon Kohden Corporation, NuVasive Inc, Procirca, ProPep Surgical, and SpecialtyCare, Inc..

Market Segmentation & Coverage

This research report categorizes the Intraoperative Neuromonitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Insource IONM and Outsource IONM.
• Based on Modality, market is studied across Brainstem Auditory Evoked Potentials, Electroencephalography, Electromyography, Motor Evoked Potentials, Somatosensory Evoked Potentials, and Visual Evoked Potentials.
• Based on Application, market is studied across ENT Surgery, Neurosurgery, Orthopedic Surgery, Spinal Surgery, and Vascular Surgery.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of various lifestyles associated chronic diseases
    • 5.1.1.2. Favorable reimbursement policies and demand for safer surgery practices
    • 5.1.1.3. Rising trend of outsourcing Intraoperative Neuromonitoring
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in neuromonitoring to minimize the risks during surgery
    • 5.1.3.2. Increased R&D investments by governmental bodies
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of skilled professionals and low awareness
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Intraoperative Neuromonitoring Market, by Type

• 6.1. Introduction
• 6.2. Insource IONM
• 6.3. Outsource IONM

7. Intraoperative Neuromonitoring Market, by Modality

• 7.1. Introduction
• 7.2. Brainstem Auditory Evoked Potentials
• 7.3. Electroencephalography
• 7.4. Electromyography
• 7.5. Motor Evoked Potentials
• 7.6. Somatosensory Evoked Potentials
• 7.7. Visual Evoked Potentials

8. Intraoperative Neuromonitoring Market, by Application

• 8.1. Introduction
• 8.2. ENT Surgery
• 8.3. Neurosurgery
• 8.4. Orthopedic Surgery
• 8.5. Spinal Surgery
• 8.6. Vascular Surgery

9. Americas Intraoperative Neuromonitoring Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Intraoperative Neuromonitoring Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Intraoperative Neuromonitoring Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Accurate Monitoring, LLC
• 2. Argos Neuromonitoring LP
• 3. Biotronic NeuroNetwork, LLC
• 4. Cadwell Industries, Inc.
• 5. Computational Diagnostics, Inc.
• 6. Emotiv Inc.
• 7. inomed Medizintechnik GmbH
• 8. Intranerve, LLC
• 9. Medsurant Health
• 10. Medtronic PLC
• 11. Moberg Research Inc.
• 12. Natus Medical Incorporated
• 13. NeuroMonitoring Technologies
• 14. NeuroSentinel LLC
• 15. Nihon Kohden Corporation
• 16. NuVasive Inc
• 17. Procirca
• 18. ProPep Surgical
• 19. SpecialtyCare, Inc.